•  
  •  
  •  
  •  

2026-03-23 22:32:06

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Dr. Reddy's Laboratories announces launch of India's first DCGI-approved Semaglutide injection 'Obeda®' for Type 2 Diabetes
  • Sun Pharma launches its semaglutide injection under the brand names, Noveltreat and Sematrinity in India
  • Zydus launches Semaglutide Injection in an innovative, reusable multi-dose pen device in India
  • Glenmark Pharmaceuticals Launches GLIPIQ® (Semaglutide) In India
  • Kiaasa Retail Ltd opens 4 retail outlets

Keywords Selected:  GMDCLTD

Stock Report

  • GMDC's Surkha(N) Lignite Mine Receives Environmental Clearance for Capacity Expansion

Latest Post

  • Dr. Reddy's Laboratories announces launch of India's first DCGI-approved Semaglutide injection 'Obeda®' for Type 2 Diabetes
  • Sun Pharma launches its semaglutide injection under the brand names, Noveltreat and Sematrinity in India
  • Zydus launches Semaglutide Injection in an innovative, reusable multi-dose pen device in India
  • Glenmark Pharmaceuticals Launches GLIPIQ® (Semaglutide) In India
  • Kiaasa Retail Ltd opens 4 retail outlets


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2025